Myriad Genetics, Inc. announced it will present significant research on early prenatal testing at the Society for Maternal-Fetal Medicine Conference. The study, awarded the Dru Carlson Memorial Award, ...
A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing can detect the risk in pregnant mothers of transmitting cytomegalovirus (CMV ...
Myriad Genetics, Inc. has launched a new educational website called "Know More Sooner," aimed at providing detailed information about reproductive and prenatal genetic testing. The site seeks to ...
A new Australian study has found that forms used for one of the most common genetic screening tests in pregnancy—costing prospective parents up to $550—are often confusing and inconsistent, blurring ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Non-invasive prenatal testing, or NIPT, now shapes critical ...
Prenatal genetic tests can detect sex chromosome aberrations, but what happens after—for families and children—is anything but clear. When Ollie’s mother, Katie, was nine weeks pregnant, her ...
Prenatal genetic testing determines if an offspring is at risk of genetic or hereditary conditions. This can inform the parents of decisions such as keeping the child or not or adjusting to help them ...
To examine whether the frequency of four screening tests during prenatal care conforms to evidence of effectiveness. We estimated rates of urine culture, anemia screening, oral glucose tolerance test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results